Current Views of Toll-Like Receptor Signaling Pathways
Open Access
- 14 December 2010
- journal article
- review article
- Published by Hindawi Limited in Gastroenterology Research and Practice
- Vol. 2010, 1-8
- https://doi.org/10.1155/2010/240365
Abstract
On microbial invasion, the host immediately evokes innate immune responses. Recent studies have demonstrated that Toll-like receptors (TLRs) play crucial roles in innate responses that lead not only to the clearance of pathogens but also to the efficient establishment of acquired immunity by directly detecting molecules from microbes. In terms of intracellular TLR-mediated signaling pathways, cytoplasmic adaptor molecules containing Toll/IL-1R (TIR) domains play important roles in inflammatory immune responses through the production of proinflammatory cytokines, nitric oxide, and type I interferon, and upregulation of costimulatory molecules. In this paper, we will describe our current understanding of the relationship between TLRs and their ligands derived from pathogens such as viruses, bacteria, fungi, and parasites. Moreover, we will review the historical and current literature to describe the mechanisms behind TLR-mediated activation of innate immune responses.Keywords
Funding Information
- Ministry of Education, Culture, Sports, Science and Technology of Japan
This publication has 91 references indexed in Scilit:
- Proteolytic cleavage in an endolysosomal compartment is required for activation of Toll-like receptor 9Nature Immunology, 2008
- TRAM couples endocytosis of Toll-like receptor 4 to the induction of interferon-βNature Immunology, 2008
- SINTBAD, a novel component of innate antiviral immunity, shares a TBK1-binding domain with NAP1 and TANKThe EMBO Journal, 2007
- TAK1, but not TAB1 or TAB2, plays an essential role in multiple signaling pathways in vivoGenes & Development, 2005
- Crystal Structure of Human Toll-Like Receptor 3 (TLR3) EctodomainScience, 2005
- Noncanonical MMS2-Encoded Ubiquitin-Conjugating Enzyme Functions in Assembly of Novel Polyubiquitin Chains for DNA RepairCell, 1999
- Review Article Imiquimod applied topically: a novel immune response modifier and new class of drugInternational Journal of Immunopharmacology, 1999
- Defective LPS Signaling in C3H/HeJ and C57BL/10ScCr Mice: Mutations in Tlr4 GeneScience, 1998
- Immune response modification: imiquimod.1998
- Drosophila Toll and IL-1 receptorNature, 1991